MedPath

To Observe How Many Patient Of Cervical Erosion Get Symptomatic Relief With Cryotherapy

Not Applicable
Completed
Conditions
Health Condition 1: N72- Inflammatory disease of cervix uteri
Registration Number
CTRI/2022/11/047036
Lead Sponsor
Rohilkhand Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Women with age between 20 to 40 years

2.Women with Intact uterus

3.Women suffering from any/ more/all of the following Symptoms- Abundant vaginal discharge , pelvic pain, Post coital bleeding, dyspareunia.

Exclusion Criteria

1.Pap smear with premalignant and malignant changes

2.Active genital tract infections

3.Women who are virgin or pregnant or lactating or have attained menopause

4.Women with medical history of OR suffering from

hypertension/ diabetes mellitus/ bleeding

disorder/any other immunocompromising disease

5.Women taking Oral contraceptive pills

6.Females with history of cervical Neoplasia or

premalignant cervical lesion (CIN-1 & CIN-2)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the symptomatic improvement among patients after cryotherapy <br/ ><br>Timepoint: 1)Baseline:07/11/22 to 07/11/23 <br/ ><br>2) 1 month (4 weeks) <br/ ><br>3) 3 months(12 weeks)
Secondary Outcome Measures
NameTimeMethod
(1) To document any complications of cryotherapy . <br/ ><br>(2) To analyze the features associated with success of cryotherapy <br/ ><br> <br/ ><br>Timepoint: 1)Baseline 07/11/22 to 07/11/23 <br/ ><br>2) 1 month (4 weeks) <br/ ><br>3) 3 months (12 weeks)
© Copyright 2025. All Rights Reserved by MedPath